MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$80,876K
Marketable securities
$78,018K
Prepaid expenses and
other current assets
$3,091K
Restricted cash
$1,250K
Total current assets
$163,235K
Operating lease
right-of-use assets
$30,949K
Restricted cash
$2,000K
Property and equipment,
net
$1,915K
Other assets
$4K
Total assets
$198,103K
Accumulated deficit
-$632,467K
Total liabilities and
stockholders deficit
$198,103K
Total stockholders
deficit
-$108,500K
Additional paid-in capital
$523,937K
Accumulated other
comprehensive gain
$24K
Common stock, 0.0001
par value...
$6K
Total liabilities
$306,603K
Deferred revenue, net of
current portion
$205,962K
Total current
liabilities
$59,738K
Operating lease
liabilities, net of current...
$40,347K
Other liabilities
$556K
Deferred revenue
$43,192K
Accrued expenses and
other current...
$11,357K
Accounts payable
$4,266K
Operating lease
liabilities
$923K
Back
Back
Balance Sheet
source: myfinsight.com
Foghorn Therapeutics Inc. (FHTX)
Foghorn Therapeutics Inc. (FHTX)